| 1 |
33140258 | Diabetes Mellitus/Poststroke Hyperglycemia: a Detrimental Factor for tPA Thrombolytic Stroke Therapy. | 2021 Jun |
1 |
| 2 |
33991465 | Precision targeting of the plasminogen activator inhibitor-1 mechanism increases efficacy of fibrinolytic therapy in empyema. | 2021 May |
3 |
| 3 |
30579151 | Assessment and determinants of whole blood and plasma fibrinolysis in patients with mild bleeding symptoms. | 2019 Feb |
1 |
| 4 |
30597502 | tPA Point Mutation at Autolysis Loop Enhances Resistance to PAI-1 Inhibition and Catalytic Activity. | 2019 Jan |
8 |
| 5 |
30733557 | Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1. | 2019 Feb 7 |
3 |
| 6 |
29324332 | Impaired plasminogen binding in patients with venous thromboembolism: Association with protein carbonylation. | 2018 Mar |
1 |
| 7 |
30135637 | Can components of the plasminogen activation system predict the outcome of kidney transplants? | 2018 |
1 |
| 8 |
28018998 | Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause. | 2017 Mar |
1 |
| 9 |
28785222 | Inhibition of PAI-1 Activity by Toddalolactone as a Mechanism for Promoting Blood Circulation and Removing Stasis by Chinese Herb Zanthoxylum nitidum var. tomentosum. | 2017 |
1 |
| 10 |
27197780 | A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase. | 2016 Oct |
2 |
| 11 |
25615797 | Small molecules inhibitors of plasminogen activator inhibitor-1 - an overview. | 2015 Mar 6 |
1 |
| 12 |
25617690 | A small molecule PAI-1 functional inhibitor attenuates neointimal hyperplasia and vascular smooth muscle cell survival by promoting PAI-1 cleavage. | 2015 May |
2 |
| 13 |
24669362 | SERPINE1: A Molecular Switch in the Proliferation-Migration Dichotomy in Wound-"Activated" Keratinocytes. | 2014 Mar 1 |
3 |
| 14 |
23988002 | Plasminogen activator inhibitor with very long half-life (VLHL PAI-1) can reduce bleeding in PAI-1-deficient patients. | 2013 Aug |
2 |
| 15 |
21663586 | Val17Ile single nucleotide polymorphisms similarly as Ala15Thr could be related to the lower secretory dynamics of PAI-1 secretion: theoretical evidence. | 2011 Aug |
2 |
| 16 |
21976662 | Effects of extracellular DNA on plasminogen activation and fibrinolysis. | 2011 Dec 9 |
1 |
| 17 |
22078535 | Development of inhibitors of plasminogen activator inhibitor-1. | 2011 |
2 |
| 18 |
22257230 | [Plasminogen activator system and its clinical significance in patients with a malignant disease]. | 2011 |
1 |
| 19 |
19855086 | Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial cells. | 2010 Sep |
5 |
| 20 |
25214955 | Efficacy of a new mutated recombinant tissue-type plasminogen activator in beagles with acute coronary artery thrombi. | 2010 |
1 |
| 21 |
19082507 | VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form. | 2009 Jan |
3 |
| 22 |
19273183 | PAI-1 and kidney fibrosis. | 2009 Jan 1 |
1 |
| 23 |
19482637 | Blood biomarkers to guide stroke thrombolysis. | 2009 Jun 1 |
1 |
| 24 |
19483400 | Secretory dynamics of tPA and its modulation by PAI-1 in vascular system. | 2009 May |
1 |
| 25 |
18337662 | Intragraft coagulation events and delayed graft function in clinical renal transplantation. | 2008 Mar 15 |
1 |
| 26 |
17135721 | Serum levels of vitamin D and haemostatic factors in healthy subjects: the Tromsø study. | 2007 |
1 |
| 27 |
17896949 | Structure-function relationships of plasminogen activator inhibitor-1 and its potential as a therapeutic agent. | 2007 Sep |
2 |
| 28 |
16409470 | Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesis. | 2006 Jan |
1 |
| 29 |
15547925 | Massive intra-abdominal bleeding due to injury in the mesenteric artery during late breast reconstruction with a free TRAM flap: a case report. | 2005 |
1 |
| 30 |
15574370 | S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. | 2005 Jan 1 |
1 |
| 31 |
15780477 | Induction of plasminogen activator inhibitor-1 and -2 in dorsal root ganglion neurons after peripheral nerve injury. | 2005 |
3 |
| 32 |
15023541 | Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer. | 2004 Apr 1 |
2 |
| 33 |
15033993 | Protonation state of a single histidine residue contributes significantly to the kinetics of the reaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator. | 2004 May 28 |
2 |
| 34 |
15175025 | Signaling events during induction of plasminogen activator inhibitor-1 expression by sphingosylphosphorylcholine in cultured human dermal fibroblasts. | 2004 Jun |
4 |
| 35 |
15175801 | Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator. | 2004 Jun |
2 |
| 36 |
15493875 | Non-muscle alpha-actinin-4 interacts with plasminogen activator inhibitor type-1 (PAI-1). | 2004 Sep |
1 |
| 37 |
12581266 | Do plasminogen activator inhibitor (PAI-1) or tissue plasminogen activator PAI-1 complexes predict complications in Type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study. | 2003 Feb |
7 |
| 38 |
12706368 | The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology. | 2003 May |
1 |
| 39 |
12841345 | Impact and mechanism for oxidized and glycated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells. | 2003 Apr |
1 |
| 40 |
14594325 | Subjects with a shortened activated partial thromboplastin time show increased in-hospital mortality associated with elevated D-dimer, C-reactive protein and glucose levels. | 2003 |
3 |
| 41 |
14976916 | [Vascular endothelial growth factor and plasminogen activators in endometrial carcinoma and hyperplasia]. | 2003 |
1 |
| 42 |
11928815 | The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor type-1: roles of the reactive centre loop, the shutter region, the flexible joint region and the small serpin fragment. | 2002 Jan |
2 |
| 43 |
12167592 | Biphasic regulation of plasminogen activator/inhibitor by LDL in mesangial cells. | 2002 Sep |
1 |
| 44 |
12223472 | Mechanisms of conversion of plasminogen activator inhibitor 1 from a suicide inhibitor to a substrate by monoclonal antibodies. | 2002 Nov 15 |
2 |
| 45 |
12271109 | Diurnal variations in coagulation and fibrinolysis in vital exhaustion. | 2002 Sep-Oct |
1 |
| 46 |
11113116 | A truncated plasminogen activator inhibitor-1 protein induces and inhibits angiostatin (kringles 1-3), a plasminogen cleavage product. | 2001 Mar 16 |
3 |
| 47 |
11220710 | The influence of weight loss on fibrinolytic and metabolic parameters in obese children and adolescents. | 2001 Jan |
1 |
| 48 |
11299067 | Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas. | 2001 |
2 |
| 49 |
11341521 | The expression of exercise-induced tPA activity in blood is regulated by the basal level of PAI-1. | 2001 Apr |
1 |
| 50 |
11398145 | Interrelationship between estimates of adiposity and body fat distribution with metabolic and hemostatic parameters in obese children. | 2001 Jun |
1 |